SHL Medical has adopted a new reusable electromechanical autoinjector Elexy which changes how new drugs are trialled and commercialised, shortening these processes.
Broughton has launched the latest version of Tox HQ, an online data-driven tool that allows customers to confidentially submit its products for toxicological assessment.
Gerresheimer, a system and solution provider and a global partner for the pharma, biotech and cosmetic industries, is presenting Gx Elite vials, designed to maximise patient safety and production efficiency through a quality by design approach.
Ahead of CPHI Milan, EPM spoke to Thierry Van Nieuwenhove, CEO of Quotient Sciences, to explore how the company is innovating to meet the growing demand for personalised medicine through AI, partnerships and meeting sustainability goals.
Recipharm and Exela Pharma Sciences announced an exclusive strategic alliance aimed at enhancing sterile manufacturing capabilities in the United States.
Ahead of CPHI Milan, EPM spoke to Hayley Crowe, executive vice president and general manager of Ecolab's Global Life Sciences sector, to discuss the company's approach to addressing the growing demand of cell and gene therapies (C>s).
Semaglutide usage has surged in recent years due to FDA approval for its wider usage in weight loss management, providing a legal and regulated avenue for the drug to be prescribed.
PCI Pharma Services, (“PCI”) a global contract development and manufacturing organisation (CDMO) focused on biopharma’s most complex therapies, is investing more than $365 million in infrastructure.
